PowderPNC27

PNC-27

Bulk≥99.5% Purity

Pharmaceutical-grade PNC-27 for oncology research applications targeting HDM-2 overexpressing cells.

Request a Quote

Pricing available for qualified medical professionals, clinics, and distributors.

Enquire NowDownload MonographView FAQ

Mechanism of Action

PNC-27 contains an HDM-2-binding domain (residues 12-26 of p53) linked to a membrane-penetrating peptide. It binds HDM-2 on the surface of cells overexpressing this oncoprotein, causing rapid membrane lysis via pore formation. Normal cells lacking surface HDM-2 are unaffected.

Clinical Benefits

  • Selective targeting of HDM-2 overexpressing cells
  • Membrane-lytic mechanism of action
  • Spares normal healthy cells
  • Research applications in oncology

Specifications

TargetHDM-2 oncoprotein
Purity≥99.5% (HPLC verified)
FormBulk powder (per gram)

Storage & Handling

  • Store at -20°C
  • Protect from light

For professional medical use only. Not for retail sale to the general public. Pricing available on request for qualified medical institutions and distributors.